菜单
For adult patients with diabetes undergoing elective surgical procedures, aim for preoperative hemoglobin A1c below 8% and blood glucose concentrations between 100 to 180 mg/dL. Triggered by questions such as "What preoperative glycemic targets should we set for this surgical patient?"
默认使用会先检查来源的 Prompt；你也可以切换为直接命令，或下载本地副本。
决定是否安装前，请先阅读 SKILL.md，以及 SkillsMP 当前展示的配套文件。
用 Codex 或 Claude 帮你安装 复制这段 Prompt，粘贴到 Codex、Claude 或其他助手里，让它检查 Skill 页面并帮你完成安装。
直接命令不会经过审查 Prompt；运行前请先检查来源。
npx skills add https://github.com/dromlakhani/MD2SKILL --skill es-preop-target-hba1c-bg命令会保持在同一行。复制前请横向滚动并检查完整内容。
想先保存到本地？可下载 SkillsMP 当前能够提供的文件。
For a person with confirmed islet autoantibodies (early-stage type 1 diabetes), state the numerical progression risk to Stage 3 T1D by stage and age, set the age-stratified monitoring frequency (metabolic and HbA1c), apply the ≥10% longitudinal HbA1c rise → OGTT rule, and give the standard risk-modifier and communication framing. Use when a clinician asks how often should I monitor this Stage 1 child, what's the risk of this teenager progressing to insulin, adult with GAD positive what's the 5-year risk, my patient's HbA1c has risen 12% is that important, single autoantibody how often to retest, or how to counsel a family about progression risk. Grounded in Phillip et al. Diabetologia 2024 international staging and monitoring consensus, cross-referenced with Hussain et al 2026 IDF Europe roadmap.
Order and confirm islet autoantibody screening for early-stage type 1 diabetes — which antibodies to test (GAD65, IAA, IA2, ZnT8), sample types (capillary dried blood spot, venous), the mandatory two-sample two-method confirmation protocol, and how to interpret a positive, negative, or single-antibody result. Use when a clinician asks how to screen for early T1D, which islet autoantibodies to order, how to confirm a positive T1D antibody screen, is one autoantibody enough for T1D diagnosis, GAD antibody positive what next, or is running a general population or family-history T1D screening program. Grounded in Hussain et al 2026 (Diabetes, Obesity and Metabolism, IDF Europe consensus, DOI 10.1111/dom.70569).
Classify a person with a positive islet autoantibody screen into a specific stage of type 1 diabetes (At Risk / Stage 1 / Stage 2a / Stage 2b / Stage 3a / Stage 3b / Stage 4) using the international consensus staging framework based on autoantibody count and glycaemic status. Use when a clinician asks how to stage a positive autoantibody screen, what stage of T1D is this, is this early-stage T1D, does this child need insulin yet, is this presymptomatic T1D, does this qualify for teplizumab, or presents a person with any combination of islet autoantibodies + glucose data. Applies across paediatric and adult populations. Grounded in Hussain et al 2026 (Diabetes, Obesity and Metabolism, IDF Europe consensus, DOI 10.1111/dom.70569).
基于 SOC 职业分类
正在显示 SKILL.md
| name | es-preop-target-hba1c-bg |
| description | For adult patients with diabetes undergoing elective surgical procedures, aim for preoperative hemoglobin A1c below 8% and blood glucose concentrations between 100 to 180 mg/dL. Triggered by questions such as "What preoperative glycemic targets should we set for this surgical patient?" |
Collect diabetes type, recent HbA1c (within 3 months), recent blood glucose levels, comorbidities affecting HbA1c accuracy (e.g., anemia, hemoglobinopathies, chronic kidney disease, alcoholism), current diabetes medications, and timing of elective surgery. Action: If HbA1c unavailable, order stat HbA1c and obtain fasting/random BG; then proceed to step 2.
Is it feasible to achieve HbA1c <8% before surgery? (Consider time until surgery ≥4 weeks and patient’s ability to intensify therapy). Decision: If yes, target HbA1c <8% and proceed to step 3; if no, skip HbA1c target and proceed to step 3 focusing on BG 100-180 mg/dL.
Classify HbA1c: <8% (target met), 8-9% (moderately elevated), ≥9% (significantly elevated). Action: For HbA1c ≥8%, initiate or intensify glucose-lowering therapy (e.g., add basal insulin, adjust doses) and recheck HbA1c in 2-4 weeks; for HbA1c <8%, verify BG 100-180 mg/dL 1-4 hours pre-op.
Based on classification: If HbA1c <8% and BG 100-180 mg/dL 1-4 hours pre-op, proceed with surgery; if HbA1c ≥8% despite optimization, consider delaying elective surgery until target met; if BG persistently <100 or >180 mg/dL, adjust insulin regimen (e.g., reduce basal if hypoglycemia, add correctional insulin if hyperglycemia) and recheck. Decision: Clearance for surgery when both targets met or clinically deemed safe after optimization.
Do not rely on HbA1c if patient has conditions affecting its accuracy (anemia, hemoglobinopathies, chronic renal failure, alcoholism, drugs causing falsely low/high HbA1c, large BG fluctuations); avoid hypoglycemia (<70 mg/dL) when intensifying therapy; do not administer preoperative carbohydrate-containing oral fluids; avoid delaying surgery unnecessarily for urgent cases; ensure BG measured 1-4 hours pre-op, not just fasting.
A 62-year-old man with type 2 diabetes scheduled for elective hernia repair in 3 weeks has HbA1c 8.6% and fasting BG 150 mg/dL. He has no anemia or CKD. Step 1: collect data. Step 2: feasible to lower HbA1c (3 weeks available). Step 3: HbA1c 8-9% → intensify therapy (add basal insulin 10 units nightly). Step 4: after 2 weeks, HbA1c 7.8%, BG 130 mg/dL pre-op → proceed with surgery.
Source: Management of Hyperglycemia in Hospitalized Adult Patients in Non-Critical Care Settings: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2022, https://doi.org/10.1210/clinem/dgac278
TODO: consider adding scripts/calc.py for the es-preop-target-hba1c-bg calculator